Cannabis use and brain structural alterations in first episode schizophrenia - A region of interest, voxel based morphometric study

Schizophrenia Research

Volumn 99, Issue 1-3, 2008, Pages 1-6

  Bangalore, Srihari S ^a   Prasad, Konasale M R ^a   Montrose, Debra M ^a   Goradia, Dhruman D ^a   Diwadkar, Vaibhav A ^a,b   Keshavan, Matcheri S ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabis; Magnetic resonance imaging; Posterior cingulate; Schizophrenia; Voxel based morphometry

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABIS;

ADULT; ARTICLE; BASAL GANGLION; BRAIN FUNCTION; BRAIN REGION; CEREBELLUM; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; MALE; MORPHOMETRICS; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; BRAIN; CANNABINOIDS; DOMINANCE, CEREBRAL; FEMALE; GYRUS CINGULI; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA ABUSE; MATHEMATICAL COMPUTING; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTIC DISORDERS; RECEPTOR, CANNABINOID, CB1; SCHIZOPHRENIA;

EID: 39149145495     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.11.029     Document Type: Article

References (29)

1. Barnett J.H., Werners U., Secher S.M., Hill K.E., Brazil R., Masson K., et al. Substance use in a population-based clinic sample of people with first-episode psychosis. Br. J. Psychiatry. 190 (2007) 515-520
2. Bersani G., Orlandi V., Kotzalidis G.D., and Pancheri P. Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes. Eur. Arch. Psychiatry Clin. Neurosci. 252 (2002) 86-92
3. Block R.I., O'Leary D.S., Ehrhardt J.C., Augustinack J.C., Ghoneim M.M., Arndt S., and Hall J.A. Effects of frequent marijuana use on brain tissue volume and composition. NeuroReport 11 (2000) 491-496
4. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol. Psychiatry 57 (2005) 1117-1127
5. D'Souza D.C., Perry E., MacDougall L., Ammerman Y., Cooper T., Wu Y.T., et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29 (2004) 1558-1572
6. Delisi L.E., Bertisch H.C., Szulc K.U., Majcher M., Brown K., Bappal A., and Ardekani B.A. A preliminary DTI study showing no brain structural change associated with adolescent cannabis use. Harm Reduct. 3 (2006) 17 (J)
7. Eggan S.M., and Lewis D.A. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb. Cortex 17 (2007) 175-191
8. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?. J. Psychiatr. Res. 17 (1982) 319-334
9. Gilbert A.R., Rosenberg D.R., Harenski K., Spencer S., Sweeney J.A., and Keshavan M.S. Thalamic volumes in patients with first-episode schizophrenia. Am. J. Psychiatry 158 (2001) 618-624
10. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., and Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14 (2001) 21-36
11. Grant B.F., Hasin D.S., Stinson F.S., Dawson D.A., June Ruan W., Goldstein R.B., et al. Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol. Med. 35 (2005) 1747-1759
12. Herkenham M., Lynn A.B., de Costa B.R., and Richfield E.K. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 547 (1991) 267-274
13. Keshavan M.S., Anderson S., and Pettegrew J.W. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J. Psychiatr. Res. 28 (1994) 239-265
14. Lewis D.A., and Moghaddam B. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch. Neurol. 63 (2006) 1372-1376
15. Lieberman J.A., Tollefson G.D., Charles C., Zipursky R., Sharma T., Kahn R.S., et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch. Gen. Psychiatry 62 (2005) 361-370
16. Maldjian J.A., Laurienti P.J., Kraft R.A., and Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19 (2003) 1233-1239
17. Matochik J.A., Eldreth D.A., Cadet J.L., and Bolla K.I. Altered brain tissue composition in heavy marijuana users. Drug Alcohol Depend. 77 (2005) 23-30
18. Mitelman S.A., Shihabuddin L., Brickman A.M., Hazlett E.A., and Buchsbaum M.S. Volume of the cingulate and outcome in schizophrenia. Schizophr. Res. 72 (2005) 91-108
19. Newell K.A., Deng C., and Huang X.F. Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. Exp. Brain Res. 172 (2006) 556-560
20. Olney J.W., and Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 52 (1995) 998-1007
21. Olney J.W., Labruyere J., and Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244 (1989) 1360-1362
22. Pantelis C., Velakoulis D., McGorry P.D., Wood S.J., Suckling J., Phillips L.J., et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361 (2003) 281-288
23. Ramaekers J.G., Kauert G., van Ruitenbeek P., Theunissen E.L., Schneider E., and Moeller M.R. High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology 31 (2006) 2296-2303
24. Robbe D., Alonso G., and Manzoni O.J. Exogenous and endogenous cannabinoids control synaptic transmission in mice nucleus accumbens. Ann. N.Y. Acad. Sci. 1003 (2003) 212-225
25. Shenton M.E., Dickey C.C., Frumin M., and McCarley R.W. A review of MRI findings in schizophrenia. Schizophr. Res. 49 (2001) 1-52
26. Shimizu E., Hashimoto K., Ochi S., Fukami G., Fujisaki M., Koike K., et al. Posterior cingulate gyrus metabolic changes in chronic schizophrenia with generalized cognitive deficits. J. Psychiatr. Res. 41 (2007) 49-56
27. Szeszko P.R., Robinson D.G., Sevy S., Kumra S., Rupp C.I., Betensky J.D., et al. Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia. Br. J. Psychiatry 190 (2007) 230-236
28. Velakoulis D., Wood S.J., Wong M.T., McGorry P.D., Yung A., Phillips L., et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch. Gen. Psychiatry 63 (2006) 139-149
29. Winsauer P.J., Lambert P., and Moerschbaecher J.M. Cannabinoid ligands and their effects on learning and performance in rhesus monkeys. Behav. Pharmacol. 10 (1999) 497-511